Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complicated Skin and Skin Structures Infections (cSSSI)”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Large-scale testing (Phase 3)Study completedNCT00091819
What this trial is testing

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

Who this might be right for
Staphylococcal Skin Infection
Cumberland Pharmaceuticals 862
Testing effectiveness (Phase 2)Study completedNCT01128530
What this trial is testing

Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)

Who this might be right for
Complicated Skin and Skin Structure Infections
Furiex Pharmaceuticals, Inc 161
Not applicableStudy completedNCT01293435
What this trial is testing

Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections

Who this might be right for
Community Acquired Pneumonia (CAP)Complicated Skin and Skin Structures Infections (cSSSI)
AstraZeneca 4,035
Post-approval studies (Phase 4)Study completedNCT00488761
What this trial is testing

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI

Who this might be right for
Skin Diseases, Infectious
Wyeth is now a wholly owned subsidiary of Pfizer 50
Testing effectiveness (Phase 2)Study completedNCT00077675
What this trial is testing

Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Who this might be right for
Infections, Gram-positive Bacterial
Cumberland Pharmaceuticals 201
Large-scale testing (Phase 3)Ended earlyNCT00865280
What this trial is testing

Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Who this might be right for
Skin Diseases, Infectious
Paratek Pharmaceuticals Inc 143
Testing effectiveness (Phase 2)Study completedNCT00426933
What this trial is testing

Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections

Who this might be right for
Soft Tissue Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 100
Large-scale testing (Phase 3)Study completedNCT00303550
What this trial is testing

Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)

Who this might be right for
Skin Diseases, Bacterial
Arpida AG
Large-scale testing (Phase 3)Study completedNCT00107978
What this trial is testing

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

Who this might be right for
Staphylococcal Skin Infection
Cumberland Pharmaceuticals 1,035
Testing effectiveness (Phase 2)Study completedNCT00061633
What this trial is testing

Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Who this might be right for
Infections, Gram-Positive BacterialAbscessBurns+3 more
Cumberland Pharmaceuticals 169
Large-scale testing (Phase 3)Study completedNCT00299520
What this trial is testing

Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)

Who this might be right for
Complicated Skin and Skin Structure Infection
Arpida AG
Large-scale testing (Phase 3)Study completedNCT00424190
What this trial is testing

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections

Who this might be right for
Bacterial Infections
Forest Laboratories 698
Large-scale testing (Phase 3)Study completedNCT00423657
What this trial is testing

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections

Who this might be right for
Bacterial Infections
Forest Laboratories 680
Large-scale testing (Phase 3)Study completedNCT00772447
What this trial is testing

China Registration Study in Patients With Skin Infections

Who this might be right for
Skin DiseasesInfectious
AstraZeneca 265
Large-scale testing (Phase 3)Study completedNCT00828971
What this trial is testing

Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs

Who this might be right for
Infectious Diseases
Bayer 16
Post-approval studies (Phase 4)Study completedNCT01419184
What this trial is testing

Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA

Who this might be right for
Staphylococcal Skin Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 250
Large-scale testing (Phase 3)WithdrawnNCT00876850
What this trial is testing

Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Who this might be right for
Skin Structures and Soft Tissue Infections
Paratek Pharmaceuticals Inc
Testing effectiveness (Phase 2)Study completedNCT03716024
What this trial is testing

Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Who this might be right for
Infectious Skin DiseaseBacterial Skin Disease
Paratek Pharmaceuticals Inc 234
Post-approval studies (Phase 4)Ended earlyNCT01104662
What this trial is testing

Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment

Who this might be right for
Complicated Skin and Skin Structure InfectionsS. Aureus BacteremiaRenal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 92
Testing effectiveness (Phase 2)Study completedNCT00442832
What this trial is testing

TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection

Who this might be right for
Staphylococcal Skin Infection
Theravance Biopharma 203